Literature DB >> 25302939

Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012.

S Y C Tong1, L Varrone1, M D Chatfield1, M Beaman2, P M Giffard1.   

Abstract

Hospital-based studies have determined high rates of community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Indigenous populations. However, there is a paucity of community-based data. We obtained 20 years (1993-2012) of data on S. aureus isolates (N = 20 210) collected from community clinics that provide services for Indigenous communities in the Northern Territory, Australia. Methicillin resistance increased from 7% to 24%, resistance to macrolides remained stable at ~25%, and there was a slight increase in resistance to trimethoprim-sulfamethoxazole. The increase in methicillin resistance is concerning for the Indigenous communities represented by this data, but it is also of significance if virulent MRSA clones emerge and spread more widely from such settings.

Entities:  

Keywords:  trimethoprim-sulfamethoxazole

Mesh:

Substances:

Year:  2014        PMID: 25302939      PMCID: PMC9507213          DOI: 10.1017/S0950268814002611

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  12 in total

Review 1.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

2.  Skin disease in the first two years of life in Aboriginal children in East Arnhem Land.

Authors:  Erin McMeniman; Libby Holden; Therese Kearns; Danielle B Clucas; Jonathan R Carapetis; Bart J Currie; Christine Connors; Ross M Andrews
Journal:  Australas J Dermatol       Date:  2011-09-02       Impact factor: 2.875

3.  Community-associated MRSA from the Indian subcontinent.

Authors:  Steven Y C Tong; Angela M Kearns
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

Review 4.  Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations.

Authors:  Steven Y C Tong; Malcolm I McDonald; Deborah C Holt; Bart J Currie
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

5.  Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia.

Authors:  E E Udo; J W Pearman; W B Grubb
Journal:  J Hosp Infect       Date:  1993-10       Impact factor: 3.926

6.  Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.

Authors:  Patricia C Valery; Peter S Morris; Catherine A Byrnes; Keith Grimwood; Paul J Torzillo; Paul A Bauert; I Brent Masters; Abbey Diaz; Gabrielle B McCallum; Charmaine Mobberley; Irene Tjhung; Kim M Hare; Robert S Ware; Anne B Chang
Journal:  Lancet Respir Med       Date:  2013-09-17       Impact factor: 30.700

7.  Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial.

Authors:  Asha C Bowen; Steven Y C Tong; Ross M Andrews; Irene M O'Meara; Malcolm I McDonald; Mark D Chatfield; Bart J Currie; Jonathan R Carapetis
Journal:  Lancet       Date:  2014-08-26       Impact factor: 79.321

8.  Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes.

Authors:  Steven Y C Tong; Emma J Bishop; Rachael A Lilliebridge; Allen C Cheng; Zornitsa Spasova-Penkova; Deborah C Holt; Philip M Giffard; Malcolm I McDonald; Bart J Currie; Craig S Boutlis
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226

Review 9.  Waves of resistance: Staphylococcus aureus in the antibiotic era.

Authors:  Henry F Chambers; Frank R Deleo
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

10.  Adaptive change inferred from genomic population analysis of the ST93 epidemic clone of community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Timothy P Stinear; Kathryn E Holt; Kyra Chua; Justin Stepnell; Kellie L Tuck; Geoffrey Coombs; Paul Francis Harrison; Torsten Seemann; Benjamin P Howden
Journal:  Genome Biol Evol       Date:  2014-02       Impact factor: 3.416

View more
  24 in total

Review 1.  Community-associated methicillin-resistant Staphylococcus aureus infection: Literature review and clinical update.

Authors:  Kassandra Loewen; Yoko Schreiber; Mike Kirlew; Natalie Bocking; Len Kelly
Journal:  Can Fam Physician       Date:  2017-07       Impact factor: 3.275

2.  Commensal Staphylococci Including Methicillin-Resistant Staphylococcus aureus from Dogs and Cats in Remote New South Wales, Australia.

Authors:  Gemma C Ma; Kate A Worthing; Michael P Ward; Jacqueline M Norris
Journal:  Microb Ecol       Date:  2019-05-02       Impact factor: 4.552

3.  Antibiotic resistance in uropathogens across northern Australia 2007-20 and impact on treatment guidelines.

Authors:  Will Cuningham; Shalinie Perera; Sonali Coulter; Graeme R Nimmo; Trent Yarwood; Steven Y C Tong; Teresa M Wozniak
Journal:  JAC Antimicrob Resist       Date:  2021-08-14

4.  Disease burden, associated mortality and economic impact of antimicrobial resistant infections in Australia.

Authors:  Teresa M Wozniak; Amalie Dyda; Greg Merlo; Lisa Hall
Journal:  Lancet Reg Health West Pac       Date:  2022-07-07

5.  Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

Authors:  K M Hare; K Grimwood; A B Chang; M D Chatfield; P C Valery; A J Leach; H C Smith-Vaughan; P S Morris; C A Byrnes; P J Torzillo; A C Cheng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-12       Impact factor: 3.267

6.  The rise of methicillin resistant Staphylococcus aureus: now the dominant cause of skin and soft tissue infection in Central Australia.

Authors:  E Macmorran; S Harch; E Athan; S Lane; S Tong; L Crawford; S Krishnaswamy; S Hewagama
Journal:  Epidemiol Infect       Date:  2017-08-14       Impact factor: 4.434

Review 7.  The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma.

Authors:  Asha C Bowen; Antoine Mahé; Roderick J Hay; Ross M Andrews; Andrew C Steer; Steven Y C Tong; Jonathan R Carapetis
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

8.  The microbiology of impetigo in indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage.

Authors:  Asha C Bowen; Steven Y C Tong; Mark D Chatfield; Jonathan R Carapetis
Journal:  BMC Infect Dis       Date:  2014-12-31       Impact factor: 3.090

9.  High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA.

Authors:  Susan A J Harch; Eleanor MacMorran; Steven Y C Tong; Deborah C Holt; Judith Wilson; Eugene Athan; Saliya Hewagama
Journal:  BMC Infect Dis       Date:  2017-06-07       Impact factor: 3.090

10.  A Retrospective Case-Series of Children With Bone and Joint Infection From Northern Australia.

Authors:  Anna Brischetto; Grace Leung; Catherine S Marshall; Asha C Bowen
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.